Literature DB >> 15072813

Sociocultural diversity and substance use pattern in Arunachal Pradesh, India.

H K Chaturvedi1, J Mahanta.   

Abstract

An epidemiological study on substance use was carried out to assess the prevalence and pattern of tobacco, alcohol, and opium being used commonly in ethnographic diverse population of Arunachal Pradesh, India. Representative sample of 5135 people age > or =10 years were interviewed to collect information about their habit of substance use. Over all, prevalence of substance use was 30.9% tobacco (22.8% chewers and 12.1% smokers), 30% alcohol, and 4.8% opium, which vary across location, gender, race, age, education, and occupation. Though tobacco and alcohol was commonly used among all the tribes, but high alcohol use among Tangsa and Tutsa tribes reflects strong cultural belief. Religiously, opium use was low among Christian and Hindu at lower (< 1000 m) altitude, but high among Buddhist, Indigenous, and Hindu living at higher altitude. Among males, high multivariate rate ratio of opium users was seen among the population of high altitude (9.1). Moreover, it was also high among Singpho (7.1) and Khamti (9.7) tribes living in low altitude area, which shows the strong geo-ethnographic influence. Average age at initiation of alcohol use (12.4 years) was significantly lower than tobacco (17.6 years), and opium (23.3 years) indicate social acceptability of alcohol drinking at early age. Use of multiple substances and high prevalence of opium express the alarming situation of substance misuse in the region. Besides few limitations, varied results of socio-cultural and ethnic influences recalls integrated approach to break the traditional belief associated with alcohol and drug abuse from the society.

Entities:  

Mesh:

Year:  2004        PMID: 15072813     DOI: 10.1016/j.drugalcdep.2003.12.003

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

Review 1.  Availability of data for monitoring noncommunicable disease risk factors in India.

Authors:  Magdalena Z Raban; Rakhi Dandona; Lalit Dandona
Journal:  Bull World Health Organ       Date:  2011-09-27       Impact factor: 9.408

2.  Sociodemographic and substance use correlates of repeated relapse among patients presenting for relapse treatment at an addiction treatment center in Kolkata, India.

Authors:  M Sau; A Mukherjee; N Manna; S Sanyal
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

3.  Factors associated with history of drug use among female sex workers (FSW) in a high HIV prevalence state of India.

Authors:  Gajendra Kumar Medhi; Jagadish Mahanta; Michelle Kermode; Ramesh S Paranjape; Rajatashuvra Adhikary; Sanjib Kumar Phukan; P Ngully
Journal:  BMC Public Health       Date:  2012-04-05       Impact factor: 3.295

4.  Substance use and addiction research in India.

Authors:  Pratima Murthy; N Manjunatha; B N Subodh; Prabhat Kumar Chand; Vivek Benegal
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 5.  Health behaviours & problems among young people in India: cause for concern & call for action.

Authors:  Singh Sunitha; Gopalkrishna Gururaj
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

6.  Substance use and dependence in the Union Territory of Chandigarh: Results of a household survey using a multistage stratified random sample.

Authors:  Ajit Avasthi; Debasish Basu; B N Subodh; Pramod K Gupta; Nidhi Malhotra; Poonam Rani; Sunil Sharma
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

7.  Mental health research on scheduled tribes in India.

Authors:  S V Siddhardh Kumar Devarapalli; Sudha Kallakuri; Abdul Salam; Pallab K Maulik
Journal:  Indian J Psychiatry       Date:  2020-12-12       Impact factor: 1.759

8.  Correlates of opium use: retrospective analysis of a survey of tribal communities in Arunachal Pradesh, India.

Authors:  Himanshu K Chaturvedi; Jagadish Mahanta; Ram C Bajpai; Arvind Pandey
Journal:  BMC Public Health       Date:  2013-04-10       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.